Design of the LEONORA Randomized Clinical Trial: Impact of Synbiotic Prophylaxis on Lower Gastrointestinal Symptoms Following Colorectal Cancer Surgery - Top-Institutions - MDSpire

Design of the LEONORA Randomized Clinical Trial: Impact of Synbiotic Prophylaxis on Lower Gastrointestinal Symptoms Following Colorectal Cancer Surgery

By
Ben Schöttker
Annette Kopp-Schneider
Lena Biehl
March 25, 2026
0 min

Bmc Cancer

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

Memorial Sloan Kettering Cancer Center

New York, NY
Key Differentiators
- Colorectal Surgery
- Oncology
- Microbiome Research
#2

Mayo Clinic

Rochester, MN
Key Differentiators
- Gastroenterology
- Colorectal Surgery
- Clinical Research
#3

Johns Hopkins Hospital

Baltimore, MD
Key Differentiators
- Surgical Oncology
- Microbiome Science
- Translational Research
#4

MD Anderson Cancer Center

Houston, TX
Key Differentiators
- Oncology
- Gastrointestinal Surgery
- Microbiome Therapeutics
#5

University of California, San Francisco (UCSF) Medical Center

San Francisco, CA
Key Differentiators
- Colorectal Surgery
- Microbiome Research
- Cancer Survivorship

Original Source(s)

Bmc Cancer

Design of the LEONORA Randomized Clinical Trial: Impact of Synbiotic Prophylaxis on Lower Gastrointestinal Symptoms Following Colorectal Cancer Surgery

by Ben Schöttker, Annette Kopp-Schneider, Lena Biehl
March 25, 2026

Related Content

Jama Network Open

Error in Abstract

May 15, 2026

Frontiers In Oncology

Integrated perspectives on colorectal carcinogenesis: molecular pathogenesis, genomic alterations, diagnostic paradigms, therapeutic interventions and AI–driven directions in precision oncology

by Sidharth Kumar N., Sai Kiruthiga S., Magesh Ramasamy
May 14, 2026

Frontiers In Oncology

Changes in dietary habits following a colon cancer diagnosis: insights from the prospective ECHO (Eating habits CHanges in Oncologic patients) STUDY 2.0